Clinical research - Press Releases

Date	Title	Company
17-Jan-2021	Registration Opens for SMi’s 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference (HPAPi)	SMi Group
14-Jan-2021	Ubiquigent and the University of York Awarded a Grant to Explore the Potential of Deubiquitylase (DUB) Enzyme Inhibitors to Address Neglected Tropical Diseases	Ubiquigent
14-Jan-2021	Registration Opens for SMi’s 21st Annual Pain Therapeutics Virtual Conference	SMi Group
14-Jan-2021	PureTech Founded Entity Vor Announces FDA Clearance of IND Application for VOR33	PureTech
14-Jan-2021	Medigene AG: Medigene expands patent protection of its technologies in key markets, the USA and Europe	Medigene AG
14-Jan-2021	Chi-Med Highlights Savolitinib Clinical Data to be Presented at Virtual WCLC	Chi-Med
12-Jan-2021	Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration	Boehringer Ingelheim, Enara Bio
11-Jan-2021	Darren Green, GSK, conference chair invites you to attend AI in Drug Discovery Virtual Conference	SMi Group
10-Jan-2021	Gene Therapy Market 2021 Size, Share, Booming Segments Breakdown and Detailed SWOT Analysis \| Global Players are AveXis, Novartis, REGENXBIO	MarketDigits
10-Jan-2021	Psychedelic Drugs Market 2021 to Witness Robust Expansion by 2026 \| Global Players are COMPASS, ALLERGAN, The Emmes Company, F. Hoffmann-La Roche, Pfizer, Mylan N.V.	MarketDigits
10-Jan-2021	Artificial Intelligence (AI) In Drug Discovery Market 2021 Flourishing Growth, Current and Upcoming Trends and Latest Technological Study by 2027 \| Global Players - IBM, Microsoft, Google, NVIDIA, Exscientia	MarketDigits
08-Jan-2021	Versameb Announces Management Update	Versameb
07-Jan-2021	Phesi and Sensyne Health Agree Collaboration to Advance Development of Synthetic Arms in Clinical Trials	Phesi
07-Jan-2021	Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure	Yaqrit
06-Jan-2021	The Dawn of a New Era for UK Clinical Research?	Clinical & Contract Research Association (CCRA)
04-Jan-2021	Panthera began dosing volunteers in AstraZeneca’s phase III of its long-acting antibody combination AZD7442 for the prevention of COVID-19 at its sites in Preston, North Manchester and North London	Panthera Biopartners
04-Jan-2021	Stefan Przyborski from University of Durham invites you to join 3D Cell Culture Virtual Conference	SMi Group
24-Dec-2020	Innovative drug, Carrimycin, Receives FDA Approval for International, Multi-country Phase III Clinical Trial for the treatment of severe COVID-19 in hospitalized patients	Shenyang Tonglian Group Co., Ltd
23-Dec-2020	MaxCyte to exceed 2020 Full Year market expectations	MaxCyte
23-Dec-2020	Amryt Granted Orphan Drug Designation by the FDA for AP103	Amryt